Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03817853 · BASELINE

Baseline characteristics

An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma · Source last updated 2024-04-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      113
    units
    Participants
groups
  1. description
    Participants were enrolled in an induction phase and received 6-8 cycles of obinutuzumab, combined with 6 or 8 cycles of standard chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone/prednisolone/methylprednisolone \[CHOP - 21-day cycle) or bendamustine (28-day cycle), or cyclophosphamide, vincristine, and prednisone/prednisolone/methylprednisolone \[CVP - 21-day cycle\]). Participants received an additional two doses of obinutuzumab on Days 8 and 15 of Cycle 1. The investigator was free to choose the chemotherapy for each participant.
    id
    BG000
    title
    All Participants
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          12.7
          value
          58.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          56
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          57
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          27
      title
      Asian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          82
      title
      White
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Other
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Multiple
    description
    Race
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          33
      title
      Hispanic or Latino
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          80
      title
      Not Hispanic or Latino
    description
    Ethnicity
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
population Description
The all participants population includes all enrolled participants.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      113
    units
    Participants
groups
  1. description
    Participants were enrolled in an induction phase and received 6-8 cycles of obinutuzumab, combined with 6 or 8 cycles of standard chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone/prednisolone/methylprednisolone \[CHOP - 21-day cycle) or bendamustine (28-day cycle), or cyclophosphamide, vincristine, and prednisone/prednisolone/methylprednisolone \[CVP - 21-day cycle\]). Participants received an additional two doses of obinutuzumab on Days 8 and 15 of Cycle 1. The investigator was free to choose the chemotherapy for each participant.
    id
    BG000
    title
    All Participants
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          12.7
          value
          58.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          56
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          57
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          27
      title
      Asian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          82
      title
      White
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Other
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Multiple
    description
    Race
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          33
      title
      Hispanic or Latino
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          80
      title
      Not Hispanic or Latino
    description
    Ethnicity
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
population Description
The all participants population includes all enrolled participants.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice